POETIC Partners

Dana-Farber/Children's Hospital Cancer Center

Dana Farber / Children's Hospital Cancer Center

Dana-Farber/Children's Hospital Cancer Center is a 60-year-old partnership between Children's Hospital Boston and Dana-Farber Cancer Institute that delivers comprehensive care to children with, and survivors of, all types of childhood cancers.

Our expert team includes many of the world's most experienced pediatric cancer and blood disorder specialists as well as international experts from pediatric medical subspecialties that include cardiology, neurology, neurosurgery and endocrinology, among others. Skilled pediatric oncology nurses, Child Life Specialists, resource specialists and psychosocial experts also provide care. Our team's comprehensive experience and knowledge gives young patients the best chance at survival.

Pediatric Brain Tumor Program at Dana-Farber/Children's Hospital Cancer Center

The Pediatric Brain Tumor Program at Dana-Farber/Children's Hospital Cancer Center is the largest and most active pediatric brain tumor treatment program in New England. Our integrated program brings together pediatric neurosurgeons, neuro-oncologists, neurologists, neuropathologists, radiation oncologists, and other specialists who are entirely devoted to the treatment and research of pediatric brain tumors. This multidisciplinary team provides a unique degree of specialization which translates into advanced treatment options for young patients with newly diagnosed, relapsed or refractory brain tumors.

As one of the leading research centers for the study of pediatric brain tumors, our program offers access to: advanced technologies like the intraoperative MRI; novel antiangiogenic, biologic, and immunotherapeutic therapies; and unique treatment options through our extensive clinical trial program. In addition, long-term follow-up care is provided to young brain tumor survivors through a specialized late-effects program which helps address physical, psychological, social and intellectual challenges that may be encountered as a direct result of the disease and its treatment.

Contact Information:
Contact Us | Privacy Policy | Terms & Conditions | Members | Board Powered by EmergingMed